// App-Quantinova.ai

2354 : Siglec-15 Is a Novel Immunomodulatory Protein and Therapeutic Target in Childhood Leukemia

Researchers

Presenter

  • Claire E. Pillsbury

Principal Investigators

  • Jairo A. Fonseca

  • Jodi Dougan

  • Hasan Abukharma

  • Linda N. Liu

  • Christopher C. Porter

Medical Centers

  • Department of Biostatistics of Emory University, Atlanta, GA

  • Cancer Biology Graduate Program, Emory University, Atlanta, GA

  • NextCure Inc, Beltsville, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Hematological malignancies

  • B cell lymphomas

  • Solid malignancies

  • Lymphomas

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Nucleoside diphosphate kinase A

  • Peripheral blood mononuclear cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved